Bionyra Pharma Reports Positive Interim Phase 1 Results for Long-Acting Anti-TL1A Antibody BYN-002 Bionyra Pharma, a clinical-stage biopharmaceutical company developing next-generation biologics designed to harness multi-targeted biology for immune-mediated inflammatory…
Parse Biosciences Launches Evercode MAX to Expand Single-Cell Sequencing Capacity and Reduce Research Costs Parse Biosciences, a leading provider of scalable and accessible single-cell sequencing technologies and a QIAGEN company,…
Algia Pharma Completes IND-Enabling Toxicology Study for AlgiaPak, Advancing Non-Opioid Acute Pain Treatment Toward Clinical Trials Algia Pharma, LLC has announced the successful completion of an Investigational New Drug (IND)-enabling…
Johnson & Johnson Launches Shockwave C2 Aero Fly Coronary IVL Catheter to Cut Treatment Time in Half Johnson & Johnson (NYSE: JNJ) has announced the U.S. launch of its Shockwave…
Orogen Therapeutics Selects ORO-110 and ORO-210 Development Candidates for Inflammatory Diseases Orogen Therapeutics, Inc. (“Orogen” or the “Company”) announced the selection of two development candidates, ORO-110 and ORO-210, as potential…
Neurogene to Present New NGN-401 Gene Therapy Data for Rett Syndrome at ESGCT 2026 Neurogene Inc., a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases, announced…
New Research Uncovers Immune Mechanism Driving Radiation-Induced Lung Injury Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States,…
Roquette to Showcase Advanced Pharmaceutical Excipients and Drug Delivery Innovations at AAPS PharmSci 360 2026 Roquette, a global leader in plant-based ingredients, pharmaceutical excipients and specialized pharmaceutical solutions, will present…
BeOne Medicines Advances Solid Tumor Oncology Pipeline With New Data Across Breast, Lung and Gastrointestinal Cancers at ESMO 2026 BeOne Medicines Ltd., a global oncology company, announced that it will…
MED Institute Joins Novelna’s PULSE Consortium to Advance Wearable Biosensing Technology for Post-Heart Attack Monitoring MED Institute has joined Novelna Inc. and its consortium partners in the development of the…
Portal Innovations Report Highlights Capital Efficiency and Growth Potential in Emerging U.S. Biotech Hubs Portal Innovations has announced the release of Biotech’s Next Frontier: Emerging Hubs Built for Efficiency and…
Baszucki Group Funds UAB Study Evaluating Ketogenic Therapy for Bipolar Disorder in Rural Alabama Baszucki Group has announced funding for a new clinical study investigating the potential psychiatric and metabolic…